SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative ...
JuneBrain Inc., a Baltimore-based neurotech startup, took first place at the 2025 BioChallenge Pitch Competition, held October 30 at the New Orleans BioInnovation Center (NOBIC). The annual contest ...
Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the brain and other difficult-to-reach ...
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, ...
MyChesCo on MSN
FDA grants breakthrough status to Fore Bio brain cancer drug
PHILADELPHIA, PA — The U.S. Food and Drug Administration recently granted Breakthrough Therapy Designation to plixorafenib, ...
Manifold Biotechnologies Inc. has signed a strategic research collaboration and license agreement with F. Hoffmann-La Roche Ltd. to develop next-generation brain shuttles for neurological diseases.
A new spatial transcriptomic approach captures the regulation of splicing and polyadenylation sites during pubescent brain development at near-single-cell resolution. An international collaboration, ...
Hosted on MSN
Human Brain Cells Forge Bio Computing Supercomputers
In laboratories, some are cultivating human brain cells to transform them into biological circuits for supercomputers—a concept known as “bio computing.” Though it sounds like science fiction, small ...
Discovering a common mechanism used by three anesthesia drugs could lead to a universal anesthesia-delivery system to monitor patients more effectively. When patients undergo general anesthesia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results